Regenerative Medicine with Adult Bone Marrow Derived Stem Cells

[1]  D. Kabelitz.  Nobelpreis für Medizin 1990 , 2009 .

[2]  G. Marenzi,et al.  Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. , 2007, European heart journal.

[3]  Jun-Jie Zhang,et al.  Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. , 2006, The Journal of invasive cardiology.

[4]  S. Schoenberg,et al.  Autologous Bone Marrow Stem Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor After Subacute ST-Segment Elevation Myocardial Infarction Undergoing Late Revascularization : Final Results From the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infar , 2006 .

[5]  A. Zeiher,et al.  Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.

[6]  L. Mazzini,et al.  Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis , 2006, Neurological research.

[7]  H. Johnsen,et al.  Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial Infarction (STEMMI) Trial , 2006, Circulation.

[8]  Hung Li,et al.  Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial , 2006, Canadian Medical Association Journal.

[9]  M. Cerqueira,et al.  Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. , 2006, The American journal of cardiology.

[10]  A. Ganser,et al.  Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction: Eighteen Months’ Follow-Up Data From the Randomized, Controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial , 2006, Circulation.

[11]  J. Mehta,et al.  Safety and effectiveness of granulocyte-colony stimulating factor in mobilizing stem cells and improving cytokine profile in advanced chronic heart failure. , 2006, The American journal of cardiology.

[12]  R. Kloner.  Attempts to recruit stem cells for repair of acute myocardial infarction: a dose of reality. , 2006, JAMA.

[13]  A. Zeiher,et al.  Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial , 2006, Nature Clinical Practice Cardiovascular Medicine.

[14]  M. Schwaiger,et al.  Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. , 2006, JAMA.

[15]  H. Okano,et al.  Administration of Hematopoietic Cytokines in the Subacute Phase After Cerebral Infarction Is Effective for Functional Recovery Facilitating Proliferation of Intrinsic Neural Stem/Progenitor Cells and Transition of Bone Marrow–Derived Neuronal Cells , 2006, Circulation.

[16]  S. Dymarkowski,et al.  Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial , 2006, The Lancet.

[17]  G. Moviglia,et al.  Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. , 2006, Cytotherapy.

[18]  R. Kloner,et al.  Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass. , 2005, Journal of the American College of Cardiology.

[19]  P. Wernet,et al.  Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. , 2005, Journal of the American College of Cardiology.

[20]  F. Emmrich,et al.  Transplantation of Blood-Derived Progenitor Cells After Recanalization of Chronic Coronary Artery Occlusion: First Randomized and Placebo-Controlled Study , 2005, Circulation research.

[21]  A. Caplan.  Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. , 2005, Tissue engineering.

[22]  R. Ferrari,et al.  Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. , 2005, European heart journal.

[23]  C. Nienaber,et al.  Prevention of Left Ventricular Remodeling With Granulocyte Colony-Stimulating Factor After Acute Myocardial Infarction: Final 1-year Results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE- , 2005, Circulation.

[24]  W. Wijns,et al.  Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety , 2005, Circulation.

[25]  J. Tijssen,et al.  START Trial: A Pilot Study on STimulation of ARTeriogenesis Using Subcutaneous Application of Granulocyte-Macrophage Colony-Stimulating Factor as a New Treatment for Peripheral Vascular Disease , 2005, Circulation.

[26]  Tobias Steigleder,et al.  The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. , 2005, The Journal of clinical investigation.

[27]  D. Katritsis,et al.  CORONARY ARTERY DISEASE Original Studies Transcoronary Transplantation of Autologous Mesenchymal Stem Cells and Endothelial Progenitors Into Infarcted Human Myocardium , 2005 .

[28]  H. Figulla,et al.  Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction. , 2005, American heart journal.

[29]  A. Ganser,et al.  Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium , 2005, Circulation.

[30]  Andrea Bacigalupo,et al.  Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[31]  H. Johnsen,et al.  Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. , 2005, International journal of cardiology.

[32]  A. Zander,et al.  High-potential human mesenchymal stem cells. , 2005, Stem cells and development.

[33]  I. Komuro,et al.  G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes , 2005, Nature Medicine.

[34]  C. Verfaillie.  Multipotent adult progenitor cells: an update. , 2005, Novartis Foundation symposium.

[35]  J. Stypmann,et al.  Granulocyte colony–stimulating factor–induced blood stem cell mobilisation in patients with chronic heart failure , 2005, Basic Research in Cardiology.

[36]  A. Zander,et al.  Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. , 2004, Experimental hematology.

[37]  W. Hofmann,et al.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. , 2004, Journal of the American College of Cardiology.

[38]  Fei Ye,et al.  Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. , 2004, Chinese medical journal.

[39]  S. Kitamura,et al.  G-CSF Promotes Bone Marrow Cells to Migrate into Infarcted Mice Heart, and Differentiate into Cardiomyocytes , 2004, Cell transplantation.

[40]  J. García-Sancho,et al.  Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction , 2004, Circulation research.

[41]  W. Vaughn,et al.  Improved Exercise Capacity and Ischemia 6 and 12 Months After Transendocardial Injection of Autologous Bone Marrow Mononuclear Cells for Ischemic Cardiomyopathy , 2004, Circulation.

[42]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[43]  P. Schiller,et al.  Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential , 2004, Journal of Cell Science.

[44]  D. Prockop.  Targeting gene therapy for osteogenesis imperfecta. , 2004, The New England journal of medicine.

[45]  Moustapha Hassan,et al.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.

[46]  F. Tögel,et al.  Hematopoietic stem cell mobilization-associated granulocytosis severely worsens acute renal failure. , 2004, Journal of the American Society of Nephrology : JASN.

[47]  Hyun-Jai Cho,et al.  Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial , 2004, The Lancet.

[48]  Irving L Weissman,et al.  Plasticity of Adult Stem Cells , 2004, Cell.

[49]  P. Merlet,et al.  Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. , 2003, Blood.

[50]  D. Prockop,et al.  One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  I. Buschmann,et al.  Influence of Inflammatory Cytokines on Arteriogenesis , 2003, Microcirculation.

[52]  Hung-Fat Tse,et al.  Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation , 2003, The Lancet.

[53]  Bernd Westphal,et al.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration , 2003, The Lancet.

[54]  I. Petit,et al.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. , 2002, Experimental hematology.

[55]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[56]  S. Gerson,et al.  Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) , 2002, Bone Marrow Transplantation.

[57]  Tomoki Aoyama,et al.  Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. , 2002, Biochemical and biophysical research communications.

[58]  L. Muul,et al.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[59]  F. Eberli,et al.  Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Study , 2001, Circulation.

[60]  E. Horwitz.  Marrow mesenchymal cell transplantation for genetic disorders of bone. , 2001, Cytotherapy.

[61]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[62]  I. Lemischka.  Stem cell dogmas in the genomics era. , 2001, Reviews in clinical and experimental hematology.

[63]  A. Caplan.  Mesenchymal stem cells and gene therapy. , 2000, Clinical orthopaedics and related research.

[64]  S. Gerson,et al.  Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  W. Mars,et al.  Bone marrow as a potential source of hepatic oval cells. , 1999, Science.

[66]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[67]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[68]  A. Vescovi,et al.  Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. , 1999, Science.

[69]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[70]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[71]  A I Caplan,et al.  Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. , 1995, Bone marrow transplantation.

[72]  A. Caplan.  Osteogenesis imperfecta, rehabilitation medicine, fundamental research and mesenchymal stem cells. , 1995, Connective tissue research.

[73]  A. Friedenstein.  Stromal-hematopoietic interrelationships: Maximov's ideas and modern models. , 1989, Haematology and blood transfusion.

[74]  I. Weissman,et al.  Purification and characterization of mouse hematopoietic stem cells. , 1988, Science.

[75]  A. Friedenstein,et al.  Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. , 1968, Transplantation.

[76]  L. Jacobson,et al.  Recovery from radiation injury. , 1951, Science.